Fig. 4.
In vivo activity of autologous CIK cells. Southern hybridization of bcr-abl RT-PCR products from the spleens of 12 mice injected with CML cells in matrigel followed by autologous CIK cells. Lanes 1 through 4, control mice not receiving CIK cells; lanes 5 through 8, mice treated with autologous BM-derived CIK cells; lanes 9 through 12, mice treated with autologous CIK cells derived from the peripheral blood; lane 13, buffer control; lane 14, 1 in 105 dilution of chronic-phase CML cells in murine cells.
